KRYSTAL BIOTECH INC (KRYS)
US5011471027 - Common Stock
ChartMill assigns a Buy % Consensus number of 87% to KRYS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 189.62. This target is 21.13% above the current price.
KRYS was analyzed by 17 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about KRYS.
In the previous month the buy percentage consensus was at a similar level.
KRYS was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-16 | Stifel | Reiterate | Buy -> Buy |
| 2024-02-27 | Guggenheim | Maintains | Buy -> Buy |
| 2024-02-27 | Citigroup | Maintains | Buy -> Buy |
| 2023-12-13 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2023-11-20 | Goldman Sachs | Initiate | Buy |
| 2023-11-07 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-10-24 | Cantor Fitzgerald | Initiate | Overweight |
| 2023-10-12 | Citigroup | Initiate | Buy |
| 2023-09-07 | Berenberg | Initiate | Buy |
| 2023-08-08 | Chardan Capital | Maintains | Buy -> Buy |
| 2023-08-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-03 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-05-25 | B of A Securities | Maintains | Buy -> Buy |
| 2023-05-24 | Stifel | Maintains | Buy -> Buy |
| 2023-05-22 | Chardan Capital | Maintains | Buy -> Buy |
| 2023-05-22 | Guggenheim | Maintains | Buy -> Buy |
| 2023-05-22 | Goldman Sachs | Maintains | Buy -> Buy |
| 2023-05-22 | B of A Securities | Maintains | Buy -> Buy |
| 2023-05-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-04-18 | Stifel | Initiate | Buy |
| 2023-03-01 | Goldman Sachs | Maintains | Buy |
| 2023-02-28 | Chardan Capital | Reiterate | Buy |
| 2023-02-28 | Guggenheim | Reiterate | Buy |
| 2023-02-28 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2023-02-28 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-11-08 | Chardan Capital | Maintains | Buy |
| 2022-11-07 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-25 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2022-08-09 | Chardan Capital | Maintains | Buy |